TASHNA SAMUELS: Open Payments
NPI 1154071637 · SUGAR LAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$630 in 31 payments from 10 companies in 2025. Trend: 2023 $16 · 2024 $288 · 2025 $630
Food & beverage: $630
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $306 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $71 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $68 |
| EVOKE PHARMA, INC. | 2 | $36 |
| Echosens North America, Inc. | 1 | $36 |
| Janssen Biotech, Inc. | 1 | $28 |
| Phathom Pharmaceuticals, Inc. | 1 | $27 |
| Gilead Sciences, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
| Celltrion USA Inc. | 1 | $18 |
Products named: RINVOQ, XIFAXAN, ENTYVIO, SKYRIZI, CREON, LINZESS, GIMOTI, Fibroscan.
Industry payments across TX — which companies pay providers there.
